Pediatric drugs require investments in formulation, but the market opportunity is worth the cost.
David Bergstrom
Advertisement
Articles by David Bergstrom
Advertisement
Latest Updated Articles
The Growing Pediatrics MarketPublished: August 1st 2004 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Announces New Plausible Mechanism Pathway
2
Roundup: Ovid Therapeutics and Metagenomi Announce 2025 Third Quarter Results and Leadership Updates
3
Pfizer’s Proven Playbook: Buy, Partner, Scale, Spin-Off, Optimize
4
Pharmaceutical Executive Daily: Dr. Richard Pazdur Appointed as Director CDER
5
